LEXICON PHARMACEUTICALS INC's ticker is LXRX and the CUSIP is 528872302. A total of 88 filers reported holding LEXICON PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.35 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $51,340 | -53.9% | 47,101 | -3.1% | 0.00% | 0.0% |
Q2 2023 | $111,260 | +411974.1% | 48,585 | +341.7% | 0.00% | – |
Q1 2023 | $27 | -100.0% | 11,000 | -89.5% | 0.00% | -100.0% |
Q2 2022 | $195,000 | -33.2% | 105,106 | -24.7% | 0.01% | -28.6% |
Q1 2022 | $292,000 | -50.9% | 139,601 | -7.5% | 0.01% | -30.0% |
Q4 2021 | $595,000 | +14.0% | 150,948 | +39.1% | 0.01% | +25.0% |
Q3 2021 | $522,000 | +656.5% | 108,541 | +620.7% | 0.01% | +700.0% |
Q2 2021 | $69,000 | +165.4% | 15,061 | -16.5% | 0.00% | 0.0% |
Q3 2020 | $26,000 | -62.9% | 18,034 | -48.7% | 0.00% | -66.7% |
Q2 2020 | $70,000 | +1.4% | 35,184 | -0.3% | 0.00% | -50.0% |
Q1 2020 | $69,000 | -61.0% | 35,273 | +144.8% | 0.01% | +20.0% |
Q3 2017 | $177,000 | -52.2% | 14,406 | -44.2% | 0.01% | -54.5% |
Q1 2017 | $370,000 | -12.5% | 25,827 | -15.5% | 0.01% | 0.0% |
Q4 2016 | $423,000 | -44.0% | 30,574 | -26.9% | 0.01% | -38.9% |
Q3 2016 | $756,000 | +327.1% | 41,850 | +238.8% | 0.02% | +350.0% |
Q2 2016 | $177,000 | +7.9% | 12,351 | -19.3% | 0.00% | -33.3% |
Q3 2015 | $164,000 | – | 15,299 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Ulys, L.L.C. | 4,321,214 | $37,033,000 | 100.00% |
Artal Group S.A. | 58,274,650 | $499,413,000 | 6.25% |
SECTOR GAMMA AS | 854,592 | $7,324,000 | 1.32% |
NEA Management Company, LLC | 2,382,286 | $20,416,000 | 0.91% |
Virtus ETF Advisers LLC | 89,845 | $770,000 | 0.67% |
Malaga Cove Capital, LLC | 59,701 | $512,000 | 0.28% |
MARSHALL WACE, LLP | 736,545 | $6,312,000 | 0.26% |
USS Investment Management Ltd | 2,741,942 | $22,607,000 | 0.25% |
CLEARBRIDGE, LLC | 1,172,117 | $10,045,000 | 0.22% |
WEDBUSH SECURITIES INC | 155,396 | $1,332,000 | 0.17% |